Announce Date | 05/14/2025 |
EPS Normalized Actual | $0.42 (Beat by $0.01) |
EPS GAAP Actual | $0.42 (Beat by $0.01) |
Revenue Actual | $0.245462B |
Revenue Surprise | Beat by $245.462M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.46553 |
EPS GAAP Estimate | $0.46553 |
Revenue Estimate | $0.306873B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2029 | 0 | INF | 0 | 0 | 0 |
Mar 2028 | 0 | INF | 0 | 0 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | 0 | 0.245462B | 17.34% | 245.46M |
FQ4 2024 (Dec 2024) | 0.24 | 0.24 | 0.267362B | 19.88% | 267.36M |
FQ3 2024 (Sep 2024) | 0.16 | 0.16 | 0.210993B | 20.05% | 210.99M |
FQ2 2024 (Jun 2024) | 0.19 | 0.19 | 0.254519B | 22.7% | 254.52M |
FQ1 2024 (Mar 2024) | 1.54 | 1.54 | 0.202887B | 26.8% | 202.89M |
FQ4 2023 (Dec 2023) | 0.22 | 0.22 | 0.214216B | 20.4% | 214.22M |
FQ3 2023 (Sep 2023) | 0.02 | 0.02 | 0.16869B | 22.19% | 168.69M |
FQ2 2023 (Jun 2023) | 0.17 | 0.17 | 0.196731B | 100% | 196.73M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.46553
Consensus Revenue Estimates
0.306873B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.71361 | -- | 0.69057 | 0.73665 | 1 |
FQ3 2027 (Sep 2027) | 0.52032 | -- | 0.50352 | 0.53712 | 1 |
FQ2 2027 (Jun 2027) | 0.63513 | -- | 0.61463 | 0.65563 | 1 |
FQ1 2027 (Mar 2027) | 0.50532 | -- | 0.48431 | 0.52631 | 0 |
FQ4 2026 (Oct 2026) | 0.37625 | -- | 0.3762 | 0.37629 | 0 |
FQ3 2026 (Jul 2026) | 0.48687 | -- | 0.4868 | 0.48692 | 0 |
FQ2 2026 (Jun 2026) | 0.48687 | -- | 0.48687 | 0.48687 | 0 |
FQ1 2026 (Mar 2026) | 0.36484 | -- | 0.34967 | 0.38 | 0 |
FQ4 2025 (Oct 2025) | 0.33733 | 28.85 | 0.32953 | 0.34513 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.46B | -- | 0.45B | 0.47B | 1 |
FQ3 2027 (Sep 2027) | 0.36B | -- | 0.36B | 0.37B | 1 |
FQ2 2027 (Jun 2027) | 0.44B | -- | 0.43B | 0.45B | 1 |
FQ1 2027 (Mar 2027) | 0.35B | -- | 0.34B | 0.36B | 0 |
FQ4 2026 (Oct 2026) | 0.3B | -- | 0.3B | 0.3B | 0 |
FQ3 2026 (Jul 2026) | 0.37B | -- | 0.37B | 0.37B | 0 |
FQ2 2026 (Jun 2026) | 0.37B | -- | 0.37B | 0.37B | 0 |
FQ1 2026 (Mar 2026) | 0.29B | 15.3 | 0.28B | 0.3B | 0 |
FQ4 2025 (Oct 2025) | 0.25B | -6.34 | 0.25B | 0.26B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
FQ4 2024 (Dec 2024) | 0.24 | 0.24 | 100% | |
FQ3 2024 (Sep 2024) | 0.16 | 0.16 | 100% | |
FQ2 2024 (Jun 2024) | 0.19 | 0.19 | 100% | |
FQ1 2024 (Mar 2024) | 1.54 | 1.54 | 100% | |
FQ4 2023 (Dec 2023) | 0.22 | 0.22 | 100% | |
FQ3 2023 (Sep 2023) | 0.02 | 0.02 | 100% | |
FQ2 2023 (Jun 2023) | 0.17 | 0.17 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.25B | $245.46M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.27B | $267.36M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.21B | $210.99M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.25B | $254.52M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.2B | $202.89M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.21B | $214.22M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.17B | $168.69M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.2B | $196.73M | 100% |